Related by context. All words. (Click for frequent words.) 74 serum concentrations 71 Cmax 69 plasma glucose 69 serum testosterone 68 amprenavir 67 serum calcium 67 serum phosphorus 67 #mg dose [001] 67 aspartate aminotransferase 66 serum uric acid 66 serum potassium 66 platelet aggregation 66 bronchodilation 66 fosamprenavir 66 serum phosphate levels 66 serum urate 66 steroid dexamethasone 66 serum PTH 65 plasma glucose levels 65 pharmacokinetic profile 65 alanine aminotransferase 65 coadministration 65 ascorbate 65 serum calcium levels 64 serum cortisol 64 alanine aminotransferase ALT 64 serum sodium 64 serum phosphate 64 APTIVUS r 64 antibody titers 64 prolactin levels 64 gastric pH 64 plasma pharmacokinetics 64 plasma uric acid 64 serum albumin 64 glucocorticoid 64 eosinophil count 64 serum LDL cholesterol 64 neutrophil counts 63 urinary excretion 63 HBeAg seroconversion 63 μmol L 63 #mg/day [001] 63 AST ALT 63 estradiol 63 HIV RNA 63 mcg mL 63 #mg/kg [002] 63 thyrotropin 63 cortisol concentrations 63 serum cholesterol 63 transaminases 63 lumbar spine BMD 63 NPH insulin 63 mg dose 63 nmol liter 63 serum phosphorus levels 63 insulin detemir 62 pg mL 62 mg d 62 systemic bioavailability 62 plasma HCV RNA 62 peak plasma concentrations 62 platelet reactivity 62 dosing frequency 62 viremia 62 pharmacokinetic PK profile 62 CK # plasma concentrations 62 elevated creatinine 62 isoproterenol 62 serum lipid levels 62 nanomolar 62 blood Phe levels 62 serum HBV DNA 62 serum urate levels 62 urinary oxalate 62 nM 62 nephrotoxicity 62 TNFalpha 62 virologic response 62 hemoglobin Hb 62 ACh 62 GH secretion 62 HCV replicon 62 uM 62 urinary calcium 62 parathyroid hormone PTH 62 serum IGF 62 posaconazole 62 pharmacokinetic parameters 62 plasma folate 62 plasma leptin 62 PBMCs 62 mcg BID 62 ritonavir boosted 62 lactate dehydrogenase 62 aminotransferases 62 IGFBP 62 administered subcutaneously 61 dose colchicine 61 microglial activation 61 lispro 61 nmol L 61 indinavir 61 mg kg 61 pg ml 61 triacylglycerol 61 serum testosterone levels 61 mRNA expression 61 APTIVUS 61 paricalcitol 61 PREZISTA r 61 hematological parameters 61 LEXIVA r 61 serum retinol 61 titers 61 CIMZIA TM 61 ergocalciferol 61 blood Phe 61 dose ritonavir 61 rHuPH# 61 log# copies mL 61 detemir 61 platelet inhibition 61 hemoglobin concentration 61 #OHD levels 61 CK MB 61 pharmacodynamic 61 ng ml 61 LTB4 61 piperacillin tazobactam 61 nicardipine 61 NovoLog ® Mix 61 serum potassium levels 61 blood glucose concentrations 61 glycosylated hemoglobin HbA1c 61 concentration Cmax 61 #.#mg/dL 61 octreotide LAR 61 mg TID 61 lymphocyte counts 61 glycemia 61 oxcarbazepine 61 plasma triglycerides 61 granisetron 61 d amphetamine 61 μg mL 61 #mg/day [002] 61 adalimumab 61 dosage regimens 61 dosed orally 61 timepoints 61 serum creatinine levels 60 protein excretion 60 gastric acidity 60 VAPRISOL 60 urinary calcium excretion 60 pyrazinamide 60 μg ml 60 ULORIC 60 mg kg dose 60 interferon alfa 2b 60 certolizumab 60 pharmacokinetics 60 mesalamine granules 60 μg kg 60 dose limiting toxicities 60 daunorubicin 60 dose proportional pharmacokinetics 60 candesartan cilexetil 60 intramuscularly 60 iPTH 60 FOSRENOL ® 60 dose dependently 60 bezafibrate 60 #mg doses [002] 60 dexamethasone 60 ketorolac 60 ng dL 60 #μg [001] 60 #mg [003] 60 serum leptin 60 chlorambucil 60 blood phenylalanine Phe 60 serum vitamin D 60 ibandronate 60 adrenal suppression 60 hemoglobin concentrations 60 myopathy rhabdomyolysis 60 #mg dose [003] 60 antiviral efficacy 60 sUA 60 lactate dehydrogenase LDH 60 serum glucose 60 mcg 60 hsCRP levels 60 lanthanum carbonate 60 μg 60 serum triglycerides 60 glycated hemoglobin levels 60 dose cytarabine 60 postprandial glucose 60 hyperphenylalaninemia HPA due 60 calcitonin 60 IL 1ß 60 lumbar spine bone 60 #mg/m# [002] 60 HBV DNA levels 60 vasodilators 60 IFN beta 60 corticosteroid dose 60 homocysteine concentrations 60 platelet counts 60 adiponectin levels 60 GnRH agonist 60 nanomolar range 60 LEXIVA 60 4mg/kg 60 hypomagnesemia 60 plasma fibrinogen 60 bupivacaine 60 aminotransferase ALT 60 Zoledronic acid 60 serum homocysteine 60 thyroid stimulating hormone 60 SGPT 60 abacavir lamivudine 60 creatinine ratio 60 aminotransferase levels 60 isoprostane 60 active metabolite 60 creatinine clearance 60 lipid levels 60 dose proportionality 60 ug kg 60 tipranavir 60 picomolar 60 plasma lipids 60 virological response 60 pharmacodynamic effects 60 pharmacodynamic PD 60 LDL cholesterol concentrations 60 pharmacodynamic profile 60 serum TSH 60 pyridostigmine 60 #mg dose [002] 60 leukocyte count 60 bone resorption 60 virologic suppression 60 viral load 60 plasma renin activity 60 amikacin 59 β blocker 59 macrolide antibiotic 59 IFN gamma 59 #mg BID [003] 59 R baclofen 59 IgG antibody 59 rizatriptan 59 mg QD 59 decitabine 59 PTH secretion 59 CrCl 59 ascending doses 59 mcg ml 59 subcutaneous dose 59 micromolar 59 mu g 59 systolic BP 59 3mg 59 HBeAg positive 59 subcutaneously 59 β blockers 59 HER2 expression 59 #.#mg/kg [002] 59 KAPIDEX 59 viral suppression 59 serum insulin 59 FEV1 59 Calcium intake 59 transaminase 59 urate levels 59 serum phosphorous 59 gonadotropins 59 pmol L 59 bioactivity 59 #mg/m# [001] 59 dose cyclophosphamide 59 mg BID 59 hours postdose 59 SGOT 59 miconazole 59 vWF 59 transdermal estradiol 59 vasodilatation 59 HBV DNA 59 pharmacokinetics PK 59 deferasirox 59 pharmacokinetic characteristics 59 mEq L 59 sustained virologic response 59 chloride secretion 59 lopinavir 59 desvenlafaxine succinate 59 serum estradiol 59 mcg dose 59 subcutaneous infusion 59 glomerular filtration 59 peginterferon alfa 2a 59 Elitek 59 ropivacaine 59 QTcF 59 inhaled fluticasone 59 transaminase elevations 59 Lp PLA 2 59 plus methotrexate 59 DLTs 59 remifentanil 59 intravesical 59 indomethacin 59 subcutaneously administered 59 inflammatory lesions 59 IFN α 59 fluvastatin 59 dose cohorts 59 follicle stimulating hormone FSH 59 postprandial glycemia 59 saline placebo 59 hematologic toxicity 59 aspartate aminotransferase AST 59 serum ALT 59 guanfacine 59 azacitidine 59 pressor response 59 esomeprazole 59 airway hyper responsiveness 59 urinary albumin excretion 59 sitagliptin 59 hepatic enzymes 59 postprandial insulin 59 transaminase levels 59 atazanavir ritonavir 59 intermittent dosing 59 RBP4 59 oxycodone CR 59 achieved ACR# 59 XP# Transported Prodrug 59 Plasma concentrations 59 endogenous EPO 59 paraprotein 59 tipranavir r 59 nocturnal hypoglycaemia 59 #μg [002] 59 foveal thickness 59 prednisone prednisolone 59 BENICAR HCT 59 isoenzyme 59 analgesic efficacy 59 adefovir 59 Apidra ® 59 Pharmacokinetic parameters 59 serum magnesium 59 low dose ritonavir 59 HbA1c levels 59 serum bicarbonate 59 serum aminotransferase levels 59 AZT zidovudine Retrovir 59 PASI scores 59 neutrophil count 59 TMC# r 59 receptor blocker 59 mg RDEA# 59 natriuretic peptides 59 antiandrogen 59 #.#mg [004] 58 ApoB 58 μg L 58 epoetin alpha 58 #mmHg [001] 58 PYY 58 ribavirin USP 58 HMG CoA reductase inhibitors 58 Crohn Disease Activity 58 natriuretic peptide 58 hemoglobin A1c HbA1c 58 8mg 58 salivary flow 58 osteoblast 58 serotonin synthesis 58 caspofungin 58 binding affinity 58 alicaforsen enema 58 LANTUS R 58 cholesterol LDL C 58 pharmacokinetic interactions 58 systemic toxicity 58 glomerular filtration rate 58 SHBG levels 58 hour bronchodilation 58 triglyceride concentrations 58 tolvaptan 58 COPD exacerbations 58 potent CYP#A# inhibitors 58 imatinib therapy 58 oral bioavailability 58 plasma urate 58 IGFBP 3 58 CLA supplementation 58 ug mL 58 Serum concentrations 58 #mg ritonavir 58 6mg 58 antibody responses 58 Sitagliptin 58 anti androgen 58 ARIKACE 58 ABC/3TC 58 PaO 2 58 monophosphate 58 SCIg 58 fibrinolytic 58 triacylglycerol concentrations 58 elevated ALT 58 MULTAQ 58 transgene expression 58 tiotropium bromide 58 retinal thickness 58 GHRH 58 corrected QT interval 58 busulfan 58 elastase 58 TNF α 58 creatine kinase 58 PEGylated anti 58 ursodeoxycholic acid 58 hMG 58 timepoint 58 glucose lowering 58 tolerability 58 mcg kg 58 baseline HbA1c 58 subcutaneous SC 58 glycated hemoglobin HbA1c 58 BENICAR 58 cytochrome P# #A# 58 μg dose 58 irbesartan 58 antiretroviral naive 58 flutamide 58 Serum creatinine 58 allopurinol 58 malondialdehyde 58 pulmonary exacerbations 58 immunomodulatory effects 58 virologic failure 58 viral loads 58 HCV RNA 58 PON1 enzyme 58 leptin concentrations 58 adrenocorticotropic hormone ACTH 58 EDARBI 58 erythropoietic 58 Elevated serum 58 inhibitory effects 58 budesonide pMDI 58 medroxyprogesterone acetate 58 systemic absorption 58 mg simvastatin 58 CYP3A 58 mg 58 plasma lipid 58 parasitemia 58 microg 58 prucalopride 58 plasma cortisol 58 terfenadine 58 Hb levels 58 CYP #A# 58 circulating lymphocytes 58 ISTODAX 58 dexamethasone Decadron 58 metabolite concentrations 58 nmol 58 CD4 + cell 58 platelet activation 58 seroprotective 58 mg/m2 dose 58 oral prednisolone 58 IL 1beta 58 QT QTc 58 nitrotyrosine 58 estramustine 58 clinically meaningful improvement 58 anti HBs 58 allopregnanolone 58 splenectomized patients 58 rhEPO 58 dosing 58 glucocorticoids 58 Navelbine 58 albumin excretion 58 tirofiban 58 thiazide diuretics 58 dopamine reuptake 58 serum HCV RNA 58 alkaline phosphatase 58 ALVESCO 58 glucuronide 58 lipoprotein Lp 58 ATACAND 58 antitumor effects 58 adiponectin concentrations 58 IU ml 58 verapamil 58 peginterferon alfa 2b 58 mucosal healing 58 interleukin IL -6 58 antihypertensive therapy 58 CIMZIA ™ 58 maximally tolerated dose 58 gliclazide 58 μg liter 58 Creatinine 58 myeloperoxidase 58 Cortisol levels 58 pharmacokinetic properties 58 #.#/#.# mm Hg [003] 58 #ug [002] 58 hydroxyvitamin D levels 58 autoantibody levels 58 REYATAZ r arm 58 μM 58 cTnI 58 #mg/kg [001] 58 administered orally 58 seropositive patients 58 μg d 58 8mg/kg 58 mmol l 58 ertapenem 58 anti leukemic 58 g dL 58 adenosine diphosphate ADP 58 Omacetaxine mepesuccinate 58 Cyclosporine 58 neutralizing antibody 58 mesalamine 58 antiviral activity 58 GI motility 58 antiangiogenic therapy 58 -#.# mg dL [002] 58 vitamin B# folic acid 57 GAGs 57 N telopeptide 57 thromboembolic events 57 zoledronate 57 ascending dose 57 triiodothyronine 57 proinflammatory cytokine 57 mg/m2 57 lopinavir r arm 57 tolerated dose MTD 57 subcutaneously injected 57 lopinavir r 57 salmeterol fluticasone 57 cardiovascular morbidity 57 hypokalemia 57 laxation 57 dosing interval 57 lanreotide 57 liver histology 57 liver transaminases 57 AUC0 57 Mg Uk 57 #.#mmol L [002] 57 serum clusterin levels 57 fasting plasma glucose FPG 57 Ghrelin 57 Wistar rats 57 IELT 57 IgG antibodies 57 tapentadol ER 57 etoposide 57 PSADT 57 sustained virological response 57 normal ULN 57 dehydroepiandrosterone sulfate 57 intra articular injection 57 vasopressor 57 Vaprisol 57 sUA levels 57 Peg IFN 57 hypocalcemia 57 TDF FTC 57 A1c levels 57 serum CRP 57 dose cohort 57 uricase 57 HbA 1c 57 viral kinetics 57 immunoreactivity 57 infarct size 57 insulin degludec 57 nadolol 57 Dasatinib 57 calcium phosphorus 57 receptor blockers 57 cobalamin 57 IIIa inhibitor 57 lipid parameters 57 HbF 57 serum sodium levels 57 #ng/ml 57 #ug [001] 57 EMEND 57 budesonide formoterol 57 cortisol secretion 57 detrusor 57 hypotensive 57 serum IgE 57 mcg doses 57 prostaglandin E2 PGE2 57 thiazide 57 SCr 57 lenalidomide dexamethasone 57 fluticasone furoate 57 mecamylamine 57 hypercalcemia 57 osmolality 57 etanercept 57 PSA nadir 57 mL/min/#.# m 2 57 atazanavir 57 dietary calcium intake 57 seroconversion 57 PRADAXA 57 hyperalgesia 57 sFlt 1 57 calcitriol 57 pathophysiological effects 57 clodronate 57 pharmacodynamics 57 Danazol 57 IIIa inhibitors 57 bioavailability 57 cinacalcet 57 QTc intervals 57 teriflunomide 57 CDK inhibitor 57 g dl 57 receptor activation 57 bFGF 57 mycophenolate mofetil 57 FOSRENOL R 57 leukocyte counts 57 angiotensin converting enzyme inhibitor 57 Triglyceride levels 57 log# 57 triglyceride TG 57 myelosuppression 57 IOP lowering 57 selective modulator 57 urinary albumin 57 NOAEL 57 IFN alpha 57 seroprotection 57 HepG2 cells 57 rhGH 57 postprandial blood glucose 57 Toxicities 57 quetiapine XR 57 t# c# CLA 57 HMG CoA reductase inhibitor 57 radiosensitivity 57 fasting plasma 57 selegiline 57 renal function 57 IgE antibodies 57 fluticasone salmeterol 57 ml kg 57 Lp PLA2 57 inhibitory effect 57 NT proBNP concentrations 57 vitamin D2 57 alteplase 57 rFVIIa 57 effector function 57 thiazide diuretic 57 virologic 57 relapsed MM 57 glulisine 57 VCAM 1 57 cytopenias 57 EUFLEXXA R 57 Victoza R 57 Hb A1C 57 LY# [003] 57 Eltrombopag 57 nitroprusside 57 inhaled iloprost 57 vitamin K1 57 muscarinic 57 intravenous dosing 57 intramuscular dose 57 corticosterone 57 pegfilgrastim 57 intracellular uptake 57 saquinavir 57 ketoconazole 57 Traficet EN 57 adalimumab Humira 57 QD dosing 57 estrone 57 antitumor effect 57 interferon IFN 57 parathyroid hormone 57 systemic hypotension 57 serum IgG 57 PlGF 57 virologic responses 57 fasting insulin 57 tinzaparin 57 eszopiclone 57 insulin lispro 57 serotonin reuptake 57 viral titers 57 PROMACTA 57 goserelin 57 norethindrone 57 alkaline phosphatase ALP 57 mineral density 57 cis retinoic acid 57 NAbs 57 undetectable viral 57 bosentan 57 proinflammatory cytokines 57 Estradiol 57 creatinine levels 57 tau phosphorylation 57 acetazolamide 57 Index CDAI 57 apolipoprotein B 57 antitumor activity 57 tolterodine 57 fructosamine 57 antioxidant enzyme 56 apremilast 56 nifedipine 56 benazepril 56 cardioprotective effects 56 mmol L 56 inhaled budesonide 56 tumor regressions 56 locomotor activity 56 bioavailable testosterone 56 normotensive 56 mTOR inhibitors 56 daily subcutaneous injections 56 cardiovascular calcification 56 L lysine 56 GPx 56 zolmitriptan 56 active comparator 56 nevirapine Viramune 56 rhTSH 56 systemic corticosteroids 56 triglycerides TG 56 OADs 56 acromegalic patients 56 Adalimumab 56 triacylglycerols 56 leflunomide 56 S/GSK# 56 MADRS score 56 undetectable HCV RNA 56 nelfinavir 56 coadministered 56 systolic diastolic blood 56 titrated 56 angiotensin converting enzyme inhibitors 56 pharmacokinetic profiles 56 p# activation 56 rapid virologic response 56 oral ibandronate 56 DAPT 56 corticosteroid therapy 56 5FU 56 inflammatory markers 56 tHcy 56 lopinavir ritonavir 56 CD# upregulation 56 vasoactive 56 selective agonist 56 albuminuria 56 tertile 56 cholecystokinin CCK 56 lumiracoxib 56 CVD mortality 56 aldosterone 56 urinary protein 56 xanthine oxidase inhibitor 56 oral antidiabetic medication 56 triglyceride levels 56 troponin T 56 IgG4 56 adrenomedullin 56 peripheral blood mononuclear 56 antibody titer 56 LATUDA 56 antiviral potency 56 ApoA1 56 thyroid hormone levels 56 Tmax 56 hypericin 56 lowering blood glucose 56 diastolic BP 56 azacytidine 56 5 HT2C receptor 56 Adverse events 56 CANCIDAS 56 ubiquinol 56 alpha1 56 macrophage infiltration 56 dose titration 56 euthyroid 56 EXJADE 56 detectable HCV RNA 56 ISENTRESS 56 idarubicin 56 inhibin B 56 inotropic 56 oestradiol 56 abciximab 56 incretin 56 itraconazole 56 oral prednisone 56 solifenacin 56 ACR# responses 56 CsA 56 neuroregenerative 56 Interferon alpha 56 inducible nitric oxide synthase 56 μg dL 56 biodistribution 56 Pioglitazone 56 mol L 56 mg doses 56 HPA axis 56 mg tid 56 lipid elevations 56 mL kg 56 aliskiren 56 B7 H3 56 trough FEV1 56 QTc interval 56 anticancer activity 56 dosage regimen 56 ng mL 56 PREZISTA ritonavir 56 pyridoxal 56 evaluable subjects 56 montelukast 56 renal toxicity 56 #.#mg [003] 56 hypophosphatemia 56 oral antidiabetic 56 CLA isomers 56 undetectable HBV DNA 56 magnesium intake 56 motilin 56 hyperoxia 56 metabolic acidosis 56 #mmHg [002] 56 peginterferon 56 fraction LVEF 56 Pharmacokinetic 56 elevated uric acid 56 DAVANAT 56 vivo potency 56 statin monotherapy 56 LDL cholesterol levels 56 bicalutamide 56 triglyceride 56 bile acid sequestrant 56 sodium nitroprusside 56 Fasting blood glucose 56 subclinical hypothyroidism 56 uric acid levels 56 serum lipid 56 urate lowering 56 peroxidase 56 rFSH 56 FIRMAGON 56 alfuzosin 56 subcutaneous doses 56 serum parathyroid hormone 56 PEGPH# 56 glucose concentrations 56 calculated creatinine clearance 56 ULN 56 IgG 56 HCTZ 56 alefacept 56 ZOMIG Nasal Spray 56 DOXIL 56 tHcy concentrations 56 retinol binding protein 56 proteinuria 56 bleomycin 56 alpha 2a 56 HIV HCV coinfected 56 intraperitoneal injection 56 favorable pharmacokinetic profile 56 Insulin sensitivity 56 interferon alfa 56 RBC folate 56 intermittent hypoxia 56 Aptivus ® 56 imipenem 56 CD4 + 56 mg/m2/day 56 Tekamlo 56 lowers blood glucose 56 FOLPI 56 glycosylated hemoglobin levels 56 clusterin 56 leucopenia 56 PDGF BB 56 kilogram mg kg 56 BARACLUDE ® 56 nicotinic acid 56 insulin glulisine 56 diabetic neuropathic pain 56 racemic albuterol 56 antiapoptotic 56 oral prodrug 56 renal excretion 56 db db mice 56 octreotide 56 #ß 56 urinary N telopeptide 56 hyperphosphatemia 56 calcium excretion 56 intravenously administered 56 aminobutyric acid 56 human chorionic gonadotropin hCG 56 glomerular 56 purine 56 IV bisphosphonates 56 iNOS 56 T2DM 56 albumin excretion rate 56 amphotericin B 56 H2RAs 56 serum creatinine 56 antitumor efficacy 56 oxybutynin 56 Acetate Rectal Suppositories 56 beta2 agonist 56 fasting glucose levels 56 aPTT 56 intramuscular 56 potentiation 56 ALT AST 56 vasodilatory 56 infused intravenously 56 epoetin alfa 56 Celecoxib 56 endothelial activation 56 thyroxine 56 malondialdehyde MDA 56 DPP4 56 intraocular pressure 56 undetectable viral load 56 rabeprazole 56 statistically significant reduction 56 AZOR 56 IV DHE 56 TNF alpha IL 56 Liver enzymes 56 SERCA2a 56 catecholamine 56 hepatic glucose production 56 LDL cholesterol lowering 56 IgG1 56 nucleoside analog 56 peptide BNP 56 sweat chloride 56 elevated serum creatinine 56 leukotriene 56 L PPDS 56 transferrin saturation 56 fulvestrant 56 injected subcutaneously 56 pimecrolimus 56 pressure natriuresis 56 ubiquinone 56 eculizumab therapy 56 tiotropium